Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
EUSAN is a Germany-based healthcare products company in Saarbrücken that operates within the URSAPHARM group. The company is focused on the distribution and commercialization of dietary supplements, dietetic products, cosmetic products, medical devices, and related health products rather than on a disclosed novel drug-development pipeline. Publicly visible evidence ties EUSAN to ophthalmology-adjacent and consumer health categories, including dry eye, ocular vitamins, allergy, nasal health, and skin care products sold through the broader URSAPHARM portfolio. EUSAN appears to be an operating commercial entity with production- and hygiene-related roles advertised at URSAPHARM facilities in Saarbrücken. For a biotech analyst, the company is best understood as a commercial healthcare-products affiliate/subsidiary within the URSAPHARM ecosystem, not as a standalone clinical-stage biotech.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on EUSAN.